A blood panel comes before the prescription at Meto, and the bill then arrives in two published lines: a monthly membership charged annually, and the medication at its own monthly rate on top of it.
What Meto charges
BPC-157: $85/mo — per month a la carte, on top of a $29/month membership billed at $320 annually and a one-time $149 Peptide Readiness Panel; the GI Support Stack built around the same peptide is $175/mo
TB-500: $135/mo — per month a la carte, on top of a $29/month membership billed at $320 annually and a one-time $149 Peptide Readiness Panel
Epitalon: $165/mo — per month a la carte, on top of a $29/month membership billed at $320 annually and a one-time $149 Peptide Readiness Panel; the CLARIFY stack containing it is $395/mo
Semaglutide: $199/mo — per month for the GLP-1 Family protocol, which covers compounded semaglutide and tirzepatide at one figure, on top of the $29/month membership and the $149 panel
Tirzepatide: $199/mo — per month for the GLP-1 Family protocol, which covers compounded semaglutide and tirzepatide at one figure, on top of the $29/month membership and the $149 panel
NAD+: $210/mo — per month a la carte, on top of a $29/month membership billed at $320 annually and a one-time $149 Peptide Readiness Panel; the member rate the site refers to is not published
Sermorelin: $120/mo — per month a la carte, on top of a $29/month membership billed at $320 annually and a one-time $149 Peptide Readiness Panel; the member rate the site refers to is not published
Glutathione: $95/mo — per month a la carte, on top of a $29/month membership billed at $320 annually and a one-time $149 Peptide Readiness Panel; the member rate the site refers to is not published
GHK-Cu: $135/mo — per month a la carte, on top of a $29/month membership billed at $320 annually and a one-time $149 Peptide Readiness Panel; the member rate the site refers to is not published
Tesamorelin: $295/mo — per month a la carte, on top of a $29/month membership billed at $320 annually and a one-time $149 Peptide Readiness Panel; the member rate the site refers to is not published
Meto is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
Two lines, and the seller says so
The membership and the medication are quoted separately, and each single peptide carries its own published monthly figure alongside the stacks it appears in. A shopper wanting one peptide rather than a bundle can cost it before starting an intake.
Splitting the bill in public is worth something. Several sellers in this comparison publish one blended figure and a membership only appears at checkout; here the second line is on the pricing page.
It also means no single figure on the site is the cost of therapy. The membership sits on top of every medication price, and the readiness panel sits in front of the first one.
The panel comes first, and it is priced
A Peptide Readiness Panel is required before prescribing, and its cost is printed rather than discovered during intake. Requiring bloodwork is a clinical position, and pricing it openly is the honest way to hold that position.
The panel is a one-time charge and the membership is a recurring one, so the first month costs more than the ones after it. Neither figure changes with which peptide is chosen.
Ten of the sixteen compounds this site tracks are declared here, across single-peptide protocols and named stacks. The stacks are quoted at their own figures rather than as a discount off the parts.
A stack the seller says it cannot currently sell
The SCULPT stack is the only place MOTS-c appears on this site, and its card reads that it is not currently available while awaiting FDA regulatory action.
That is a disclosure, not a defect. A seller that marks a product unavailable and explains why is doing something better than quietly removing the page, and this site records the compound as undeclared because the seller says it is not selling it.
It is also a reminder of what these compounds are. None of the peptides on this menu is an FDA-approved finished drug, and the regulatory question the card refers to is about whether a substance can be compounded at all.
The member rate, the state count, and the pharmacy
The site says medication is billed at a member rate typically fifteen to twenty-five per cent below a la carte, and never publishes what that member rate is. The figures recorded here are therefore the a la carte ones, which are the only ones stated.
The About page prints a headline saying fifty states are covered by the clinician network and enumerates none of them. A count is not a list, and this site does not reconstruct one from the other, so no state coverage is recorded on this row.
The pharmacies are described as FDA-registered and 503A and none is named. Six of the twenty-three sellers compared here name the facility that fills an order.
Who it's for
Buyers who would rather see the membership as its own line than have it folded into a medication price.
Shoppers who want a published monthly figure for a single peptide instead of only for a bundle.
Anyone who wants bloodwork before a peptide prescription and wants its cost stated up front.
People who prefer a seller that marks a product unavailable and says why rather than delisting it.
Who should look elsewhere
Anyone looking for one all-in figure, since the panel and the membership both sit on top of every medication price.
Buyers who want the member rate itself rather than a percentage range below an a la carte price.
Shoppers who need to confirm their state against a published list rather than a headline count of fifty.
Anyone wanting MOTS-c, which appears only in a stack the seller marks as not currently available.
Strengths
Splits the bill into two published lines, membership and medication, and says so plainly instead of quoting one blended figure
Publishes a monthly figure for each single peptide as well as for the stacks, so a one-peptide protocol can be costed before signing up
Marks its MOTS-c and tesamorelin stack "Not currently available while awaiting FDA regulatory action" rather than quietly delisting it
Requires a blood panel before prescribing and prices it openly at $149 instead of burying it in an intake
Trade-offs
The $149 panel and the $29 monthly membership both sit on top of every medication price, so no single figure on the site is the cost of therapy
Says medication is billed "at your member rate - typically 15-25% below a la carte" without publishing what that member rate actually is
Publishes a headline of 50 states covered by its clinician network but no state-by-state list
Describes its pharmacies only as FDA-registered and 503A; none is named anywhere on the site
How we verified this
Read the protocols page and recorded the published monthly figure for each single peptide and each named stack.
Recorded the membership charge, its annual billing, and the one-time readiness panel as separate published lines rather than merging them into the medication figures.
Read the SCULPT stack card and recorded its unavailability wording verbatim, then left MOTS-c undeclared on this row.
Recorded the member-rate sentence as published and confirmed no member rate is printed anywhere alongside it.
Checked the About page for a state list, found a headline count and no enumeration, and recorded no states.
Confirmed the operating entity from the seller's own Terms of Service rather than from the brand name.
A provider to compare Meto against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
A one-time Peptide Readiness Panel, and then a membership charged monthly but billed annually. Both are published, and both sit on top of whatever the medication costs.
Is the medication price the one I will actually be charged?
The figures recorded here are the a la carte ones, which are the only rates published. The site says members are billed fifteen to twenty-five per cent below a la carte without stating the resulting rate.
Can I get MOTS-c here?
Not currently. The only MOTS-c product is a stack whose own card says it is not available while awaiting FDA regulatory action, so this site does not record the compound as sold.
Which states are served?
The About page claims fifty states are covered by the clinician network but lists none of them. There is no published list to check a state against beforehand.
Who compounds the medication?
No pharmacy is named. The site describes its pharmacies only as FDA-registered and 503A, which describes a category of facility rather than an identifiable one.
Meto is not a paid partner; this link may earn a commission if that changes. Full disclosure.